Wechselwirkungen · Amglidia
AMGLIDIA 0.6 mg/mL oral suspension AMGLIDIA 6 mg/mL oral suspension · Abschnitt 4.5 · PDF-Seite 8–10
HOS-226728 · Präparat HOS-217644
Anabolic steroids and male Potentiation of the Hypoglycaemia sex hormones blood-glucose lowering effect Barbiturates Weakening of the Increased blood-glucose blood-glucose lowering levels effect Beta-receptor blockers Potentiation of the Hypoglycaemia blood-glucose lowering effect Signs of adrenergic Incorrect control of plasma counter-regulation to glucose hypoglycaemia may be reduced or absent Biguanides Potentiation of the Hypoglycaemia blood-glucose lowering effect Bosentan Increase liver enzymes Incorrect control of plasma glucose Calcium channel blockers Weakening of the blood- Increased blood-glucose glucose-lowering effect levels Chloramphenicol Potentiation of the Hypoglycaemia blood-glucose lowering effect Cimetidine Weakening of the blood- Increased blood-glucose glucose lowering effect levels Clarithromycin Potentiation of the blood- Hypoglycaemia glucose lowering effect Clonidine Potentiation of the blood- Hypoglycaemia glucose lowering effect Potentiation or weakening of Incorrect control of plasma the blood-glucose lowering glucose effect Signs of adrenergic counter- Incorrect control of plasma regulation to hypoglycaemia glucose may be reduced or absent Weakening of the blood- Increased blood-glucose glucose lowering effect levels Colesevelam Reduction of glibenclamide Incorrect control of plasma absorption from the glucose gastrointestinal tract Corticosteroids Weakening of the blood- Increased blood-glucose glucose lowering effect levels Coumarin derivatives Potentiation of the blood- Hypoglycaemia glucose lowering effect Potentiate or weaken the Incorrect dose of coumarin effect of coumarin derivatives administered derivatives Cyclophosphamides Potentiation of the blood- Hypoglycaemia glucose lowering effect Diazoxide Weakening of the blood- Increased blood-glucose glucose lowering effect levels Disopyramide Potentiation of the blood- Hypoglycaemia glucose lowering effect Diuretics Weakening of the blood- Increased blood-glucose glucose lowering effect levels Fenfluramine Potentiation of the blood- Hypoglycaemia glucose lowering effect Fenyramidol Potentiation of the blood- Hypoglycaemia glucose lowering effect Fibrates Potentiation of the blood- Hypoglycaemia glucose lowering effect Fluoxetine Potentiation of the blood- Hypoglycaemia glucose lowering effect Glucagon Weakening of the blood- Increased blood-glucose glucose lowering effect levels Guanethidine Potentiation of the blood- Hypoglycaemia glucose lowering effect Signs of adrenergic counter- Incorrect control of plasma regulation to hypoglycaemia glucose may be reduced or absent H2-receptor antagonists Potentiation or weakening of Incorrect control of plasma the blood-glucose lowering glucose effect Heparin Potentiation of the blood- Hypoglycaemia glucose lowering effect Ifosfamide Potentiation of the blood- Hypoglycaemia glucose lowering effect Insulin Potentiation of the blood- Hypoglycaemia glucose lowering effect Isoniazid Weakening of the blood- Increased blood-glucose glucoselowering effect levels Large doses of laxatives Weakening of the blood- Increased blood-glucose glucose lowering effect levels Long-acting Potentiation of the blood- Hypoglycaemia sulphonamides glucose lowering effect MAO inhibitors Potentiation of the blood- Hypoglycaemia glucose lowering effect Miconazole Potentiation of the blood- Hypoglycaemia glucose lowering effect Nicotinic acid (in high Weakening of the blood- Increased blood-glucose doses) glucose lowering effect levels Oestrogens Weakening of the blood- Increased blood-glucose glucose lowering effect levels Other oral antidiabetics Potentiation of the blood- Hypoglycaemia glucose lowering effect Oxypentifylline Potentiation of the blood- Hypoglycaemia glucose lowering effect Oxyphenbutazone Potentiation of the blood- Hypoglycaemia glucose lowering effect Phenothiazine derivatives Weakening of the blood- Increased blood-glucose glucose lowering effect levels Phenytoin Weakening of the blood- Increased blood-glucose glucose lowering effect levels Phosphamides Potentiation of the blood- Hypoglycaemia glucose lowering effect Probenecid Potentiation of the blood- Hypoglycaemia glucose lowering effect Progestogens Weakening of the blood- Increased blood-glucose glucose lowering effect levels Quinolone antibiotics Potentiation of the blood- Hypoglycaemia glucose lowering effect Reserpine Potentiation of the blood- Hypoglycaemia glucose lowering effect Potentiation or weakening of Incorrect control of plasma the blood-glucose lowering glucose effect Signs of adrenergic counter- Incorrect control of plasma regulation to hypoglycaemia glucose may be reduced or absent Rifampicin Weakening of the blood- Increased blood-glucose glucose lowering effect levels Thyroid hormones Weakening of the blood- Increased blood-glucose glucose lowering effect levels Salicylates Potentiation of the blood- Hypoglycaemia glucose lowering effect Sulfamethoxazole with Potentiation of the blood- Hypoglycaemia trimethoprim (Co- glucose lowering effect trimoxazole) Tetracycline compounds Potentiation of the blood- Hypoglycaemia glucose lowering effect Tritoqualine Potentiation of the blood- Hypoglycaemia glucose lowering effect
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): sulfamethoxazole (HOS-084533) trimethoprim (HOS-085184) fenfluramine (HOS-115627) tetracycline (HOS-115153) cimetidine (HOS-085835) clonidine (HOS-088594) diazoxide (HOS-088588) glucose (HOS-088412) coumarin (HOS-088372) heparin (HOS-086930) ifosfamide (HOS-091529) calcium (HOS-085615) disopyramide (HOS-085595) clarithromycin (HOS-084517) probenecid (HOS-085208) tritoqualine (HOS-115631) fluoxetine (HOS-085946) chloramphenicol (HOS-115623) guanethidine (HOS-088596) bosentan (HOS-086291) colesevelam (HOS-112356) isoniazid (HOS-088590) reserpine (HOS-088597) phenytoin (HOS-084531) glucagon (HOS-088589) miconazole (HOS-115630) oxyphenbutazone (HOS-226734)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-12-06T13:39:00Z · SHA-256 9b31c8fd2e2c11b31d3834841c43620453c6c194a0c4f4a1689401e4cae4ff04 · Passage 65768f222638b6ec5b55799dedba422cfd4ab929c394f7deccb2b45b8e583e53 · Zeichen 3453–12347 im Abschnitt